PharVision Advisers’s Cadiz CDZI Stock Holding History

PharVision Advisers’s Portfolio CDZI Stock Details CDZI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,409	Closed	-$238K	–	726
2025 Q3	$238K	Buy	+50,409	New	+$176K	0.13%	367

Other funds holding CDZI

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gratia Capital Los Angeles, California $227M AUM 16.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's CDZI Position: Q4 2025 in Review

PharVision Advisers sold out of Cadiz (CDZI) in Q4 2025, closing a stake of 50,409 shares — an estimated $238K sold.

PharVision Advisers first reported a position in CDZI in Q3 2025 and held it in 1 quarter. The position peaked at $238K in Q3 2025. 121 funds tracked by Wall St. Rank hold CDZI as of Q4 2025.

PharVision Advisers reported no remaining Cadiz position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 50,409 Cadiz shares in Q4 2025, an estimated $238K.
PharVision Advisers first reported a position in Cadiz in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Cadiz position peaked at $238K in Q3 2025.
121 funds tracked by Wall St. Rank held Cadiz as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.